# EDGAR Filing Document

**Accession Number:** 0001860543
**File Stem:** 0000000000-23-003227
**Filing Date:** 2023-3
**Character Count:** 8779
**Document Hash:** 3cde2a36967cb22f8343cebadb421b77
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-003227.hdr.sgml**: 20230530

**ACCESSION NUMBER**: 0000000000-23-003227

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230330

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cadre Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001860543
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 383873146
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
- **BUSINESS PHONE:** (904) 741-5400

**MAIL ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001558370-23-003915

## Text-Extract

```

United States securities and exchange commission logo

                           March 30, 2023

       Warren B. Kanders
       Chief Executive Officer
       Cadre Holdings, Inc.
       13386 International Parkway
       Jacksonville, FL 32218

                                                        Re: Cadre Holdings,
Inc.
                                                            Form 10-K for the
Fiscal Year Ended December 31, 2022
                                                            Filed March 15,
2023
                                                            File No. 001-40698

       Dear Warren B. Kanders:

              We have limited our review of your filing to the financial
statements and related
       disclosures and have the following comments. In some of our comments, we
may ask you to
       provide us with information so we may better understand your disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Form 10-K for the Fiscal Year Ended December 31, 2022

       Item 7. Management's Discussion and Analysis of Financial Condition and
Results of
       Operations, Non-GAAP Measures, page 37

   1.                                                   We note that you
provide Adjusted EBITDA less capital expenditures and Adjusted
                                                        EBITDA conversion rate,
which are non-GAAP measures, in this filing and in Exhibit
                                                        99.1 to your Form 8-K
dated March 15, 2023.

                                                              Please revise
future filings to appropriately describe and discuss Adjusted EBITDA
                                                            less capital
expenditures as a separate non-GAAP measure.
                                                              Tell us where you
provided and reconciled Adjusted EBITDA less capital
                                                            expenditures and
Adjusted EBITDA conversion rate to the most directly comparable
                                                            GAAP measure.
Reference Item 10(e) of Regulations S-K and Question 102.10 of
                                                            the Compliance &
Disclosure Interpretations on Non-GAAP Financial Measures.
 Warren B. Kanders
Cadre Holdings, Inc.
March 30, 2023
Page 2
                We reference the disclosure that Adjusted EBITDA Conversion
Rate is a liquidity
              measure. Tell us your consideration of Question 102.06 of the
Compliance
              & Disclosure Interpretations on Non-GAAP Financial Measures.
2.       Your presentation of adjusted EBITDA includes an adjustment for a
cash-based long-term
         incentive plan awarded to employees. We note a similar adjustment is
included in
         Exhibit 99.1 to your Form 8-K dated March 15, 2023. Tell us the nature
of these costs and
         your consideration of whether these are normal, recurring, cash
operating expenses
         necessary to operate your business. Refer to Question 100.01 of the
Compliance
         & Disclosure Interpretations on Non-GAAP Financial Measures.

Notes to Consolidated Financial Statements
2. Acquisitions, page 59

3.       Please tell us why you did not provide the disclosures required by ASC
805-10-50-2h for
         entities acquired during fiscal year 2022.
       In closing, we remind you that the company and its management are
responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or
absence of action by the staff.

      You may contact Christie Wong at (202) 551-3684 or Kristin Lochhead,
Senior
Accountant, at (202) 551-3664 with any questions.

                                                             Sincerely,
FirstName LastNameWarren B. Kanders
                                                             Division of
Corporation Finance
Comapany NameCadre Holdings, Inc.
                                                             Office of
Industrial Applications and
March 30, 2023 Page 2                                        Services
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

March 30, 2023

Warren B. Kanders
Chief Executive Officer
Cadre Holdings, Inc.
13386 International Parkway
Jacksonville, FL 32218

**Re: Cadre Holdings, Inc.**

**Form 10-K for the Fiscal Year Ended December 31, 2022**

**Filed March 15, 2023**

**File No. 001-40698**

Dear Warren B. Kanders:

We have limited our review of your filing to the financial statements and related disclosures and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response to these comments, we may have additional comments.

Form 10-K for the Fiscal Year Ended December 31, 2022

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Non-GAAP Measures, page 37

1. We note that you provide Adjusted EBITDA less capital expenditures and Adjusted EBITDA conversion rate, which are non-GAAP measures, in this filing and in Exhibit 99.1 to your Form 8-K dated March 15, 2023.
- Please revise future filings to appropriately describe and discuss Adjusted EBITDA less capital expenditures as a separate non-GAAP measure.
- Tell us where you provided and reconciled Adjusted EBITDA less capital expenditures and Adjusted EBITDA conversion rate to the most directly comparable GAAP measure. Reference Item 10(e) of Regulations S-K and Question 102.10 of the Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.

Warren B. Kanders
Cadre Holdings, Inc.
March 30, 2023
Page 2

- We reference the disclosure that Adjusted EBITDA Conversion Rate is a liquidity measure. Tell us your consideration of Question 102.06 of the Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.

2. Your presentation of adjusted EBITDA includes an adjustment for a cash-based long-term incentive plan awarded to employees. We note a similar adjustment is included in Exhibit 99.1 to your Form 8-K dated March 15, 2023. Tell us the nature of these costs and your consideration of whether these are normal, recurring, cash operating expenses necessary to operate your business. Refer to Question 100.01 of the Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.

# Notes to Consolidated Financial Statements

# 2. Acquisitions, page 59

3. Please tell us why you did not provide the disclosures required by ASC 805-10-50-2h for entities acquired during fiscal year 2022.

In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

You may contact Christie Wong at (202) 551-3684 or Kristin Lochhead, Senior Accountant, at (202) 551-3664 with any questions.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services